Plunkett Research Online: Novavax Inc

NOVAVAX INC (NVAX:NAS) Company Profile, Corporate Revenues, Growth, Market Size, Analysis, Business Forecasts, Market Share, Metrics, SWOT

Novavax, Inc., together with wholly-owned Swedish subsidiary, Novavax AB, is a clinical-stage biotechnology company focused on the discovery, development and commercialization of recombinant nanoparticle vaccines and adjuvants. Utilizing its innovative recombinant nanoparticle vaccine technology, N.....



Novavax Inc
Ticker: NVAX
Exchange: NAS
Parent Company:
Year Established:
Employees:
Fiscal Year Ends in

Phone: 240 268-2000
Fax: 240 268-2100
Address: 20 Firstfield Road
Gaithersburg, MD 20878 United States

Types Of Business
Industry Ranks

Industry NAICS code:

Drug Delivery Systems
Drugs-Bacterial & Viral Infection
Hormone Replacement Therapies
Contract Research Services
ContactsDescription
Stanley ErckCEO/Director/President
John TrizzinoCFO/Other Executive Officer/Senior VP/Treasurer
See More
Novavax, Inc., together with wholly-owned Swedish subsidiary, Novavax AB, is a clinical-stage biotechnology company focused on the discovery, development and commercialization of recombinant nanoparticle vaccines and adjuvants. Utilizing its innovative recombinant nanoparticle vaccine technology, N.....See More See More

Auditor: Ernst & Young LLP
Legal Advisor: Ropes & Gray LLP
$USD, In whole numbers,
except marked * or %
201720162015201420132012
Financials
    Revenue
    Cost of Revenue
    Gross Margin %
    R&D Expense
    Operating Income
    Operating Margin %
    SGA Expense
    Net Income
    Earnings Per Share
    Dividends
    Book Value Per Share
    Operating Cash Flow
    Capital Expenditure
    Free Cash Flow
Profitability
    EBITDA
    Return on Assets %
    Return on Equity %
    Net Margin %
    Assets Turnover
    Financial Leverage
Brands, Divisions and AffiliatesTop Salaries
Novavax AB
Matrix-M
NameTitleSalary (US$)Bonus (US$)
Other ThoughtsCorporate Culture

Apparent Female Officers or Directors: